6-29949483-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000706904.1(HLA-A):​c.*1794C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.65 in 151,654 control chromosomes in the GnomAD database, including 32,398 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.65 ( 32398 hom., cov: 31)

Consequence

HLA-A
ENST00000706904.1 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.307

Publications

6 publications found
Variant links:
Genes affected
HLA-A (HGNC:4931): (major histocompatibility complex, class I, A) HLA-A belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum lumen so that they can be recognized by cytotoxic T cells. They are expressed in nearly all cells. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon 1 encodes the leader peptide, exons 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region, and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. More than 6000 HLA-A alleles have been described. The HLA system plays an important role in the occurrence and outcome of infectious diseases, including those caused by the malaria parasite, the human immunodeficiency virus (HIV), and the severe acute respiratory syndrome coronavirus (SARS-CoV). The structural spike and the nucleocapsid proteins of the novel coronavirus SARS-CoV-2, which causes coronavirus disease 2019 (COVID-19), are reported to contain multiple Class I epitopes with predicted HLA restrictions. Individual HLA genetic variation may help explain different immune responses to a virus across a population.[provided by RefSeq, Aug 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.737 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000706904.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HLA-A
ENST00000706904.1
c.*1794C>T
3_prime_UTR
Exon 9 of 9ENSP00000516615.1A0A9L9PY26
HLA-A
ENST00000706902.1
n.*1708C>T
non_coding_transcript_exon
Exon 10 of 10ENSP00000516613.1A0A9L9PY26
HLA-A
ENST00000706903.1
n.*980C>T
non_coding_transcript_exon
Exon 11 of 11ENSP00000516614.1P04439-1

Frequencies

GnomAD3 genomes
AF:
0.650
AC:
98458
AN:
151538
Hom.:
32341
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.692
Gnomad AMI
AF:
0.582
Gnomad AMR
AF:
0.748
Gnomad ASJ
AF:
0.693
Gnomad EAS
AF:
0.682
Gnomad SAS
AF:
0.624
Gnomad FIN
AF:
0.604
Gnomad MID
AF:
0.661
Gnomad NFE
AF:
0.607
Gnomad OTH
AF:
0.661
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.650
AC:
98566
AN:
151654
Hom.:
32398
Cov.:
31
AF XY:
0.650
AC XY:
48123
AN XY:
74054
show subpopulations
African (AFR)
AF:
0.692
AC:
28503
AN:
41206
American (AMR)
AF:
0.749
AC:
11423
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.693
AC:
2404
AN:
3468
East Asian (EAS)
AF:
0.683
AC:
3523
AN:
5160
South Asian (SAS)
AF:
0.624
AC:
3001
AN:
4806
European-Finnish (FIN)
AF:
0.604
AC:
6364
AN:
10530
Middle Eastern (MID)
AF:
0.667
AC:
196
AN:
294
European-Non Finnish (NFE)
AF:
0.607
AC:
41233
AN:
67930
Other (OTH)
AF:
0.663
AC:
1388
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
1695
3390
5084
6779
8474
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
782
1564
2346
3128
3910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.548
Hom.:
2795
Bravo
AF:
0.663
Asia WGS
AF:
0.704
AC:
2427
AN:
3452

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
5.3
DANN
Benign
0.67
PhyloP100
-0.31

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2517716; hg19: chr6-29917260; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.